Spyridon Artavanis-Tsakonas

All filings by Spyridon Artavanis-Tsakonas on record concern Biogen Inc. We count 19 filings; the first trade dates from 12 February 2014 and the latest from 2 April 2016.

On the market, this insider has only sold: 1 sale, €551k in total. Other entries cover 9 share grants and 9 option exercises.

Most recently, on 5 April 2016, the filings show an option exercise in Biogen Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.